Type 2 & other diabetes

SGLT2 inhibitors are associated with reductions in epicardial adipose tissue volume and thickness: a meta-analysis

Int J Obes (Lond)Published Systematic review and meta-analysis

Pooled result · EATResult — go to the resultHedges g - 1.64 95% CI −2.10 to −1.18

Authors' conclusion

SGLT2i significantly reduces EAT volume and thickness, which may contribute to their broad cardiovascular benefits.

Study context

Population
Patients with serial epicardial adipose tissue (EAT) measurement by CT, echocardiography or cardiac MRI before and after SGLT2i treatment, or SGLT2i vs conventional therapy
Participants
284 patients11 studies
Comparison
SGLT2i vs conventional antidiabetic therapy; pre- vs post-SGLT2i
Outcome
Change in epicardial adipose tissue (EAT)
Methodological detailsrandom-effects models, standardised mean differences
  • Random-effects models
  • Standardised mean differences

Pooled result

EAT

Hedges g

- 1.64

95% CI −2.10 to −1.18

P < 0.01

SGLT2ivs Conventional therapy
Hedges g - 1.64 (95% CI −2.10 to −1.18); P < 0.01

As reported in the abstract

Further pooled results

EAT, baseline to follow-up with SGLT2i (exploratory within-group)

Hedges g (95% CI −0.88 to −0.36; p < 0.01)
- 0.62
  • Exploratory

EAT thickness (echocardiography), subgroup

Hedges g (95% CI −1.05 to −0.43; p < 0.01)
- 0.74
  • p = 0.32 for interaction between modalities

EAT volume (CT/CMR), subgroup

Hedges g (95% CI −0.90 to −0.18; p < 0.01)
- 0.54
  • p = 0.32 for interaction between modalities

BMI

Hedges g (95% CI −0.43 to −0.03; p = 0.03)
- 0.23

Systolic blood pressure

Hedges g (95% CI −0.59 to −0.05; p = 0.02)
- 0.32

EAT reduction by agent (exploratory subgroup)

Larger EAT reductions with dapagliflozin vs empagliflozin; indirect, small number of heterogeneous studies, hypothesis-generating only
  • Exploratory

Original publication

SGLT2 inhibitors are associated with reductions in epicardial adipose tissue volume and thickness: a meta-analysis. Int J Obes (Lond). Published 27 May 2026. doi:10.1038/s41366-026-02110-6

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.